Comments on

Pharma-funded FDA gets drugs out faster, but some work only 'marginally' and most are pricey

The FDA’s accelerated approval - which allows pharmaceutical companies to license promising treatments without proving they are effective - is usually based on a “surrogate marker” of effectiveness, but debate rages over the validity of some of these stand-ins, and some of the drugs.

Read the full story »

Comments are temporarily disabled on while we upgrade our system.

have your say   


There are no comments on this report. Sorry, comments are closed.

— 30 —


Best in Internet Exploder